CellCarta (formerly Caprion – HistoGeneX) is a leading provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Leveraging its integrated analytical platforms in immunology, histopathology, proteomics and genomics, as well as specimen collection and logistics services, CellCarta supports the entire drug development cycle, from discovery to late-stage clinical trials. With 20 years of experience providing services to the biopharma industry and a team of hundreds of scientists, including a high proportion of Ph.D., CellCarta has a strong expertise in complex assay development for clinical studies. CellCarta also offers integrated data solutions, including data management, bioinformatics, biostatistics, data interpretation, image analysis and AI/ML data interpretation. With a strong focus on Quality, CellCarta operates globally across 11 facilities located in Canada, USA, Belgium, Australia, and China.